Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

[1]  F. Montorsi,et al.  Survival after nephroureterectomy for upper tract urothelial carcinoma: A population‐based competing‐risks analysis , 2014, International journal of urology : official journal of the Japanese Urological Association.

[2]  M. Peyromaure,et al.  Bladder recurrence after radical nephroureterectomy: Predictors and impact on oncological outcomes , 2013, International journal of urology : official journal of the Japanese Urological Association.

[3]  H. Miyake,et al.  Gender as a significant predictor of intravesical recurrence in patients with urothelial carcinoma of the upper urinary tract following nephroureterectomy. , 2013, Urologic oncology.

[4]  E. Giovannucci,et al.  Original Contribution A Prospective Study of Duration of Smoking Cessation and Colorectal Cancer Risk by Epigenetics-related Tumor Classification , 2013 .

[5]  M. Babjuk,et al.  Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy. , 2013, European urology.

[6]  J. Coleman,et al.  Impact of smoking status at diagnosis on disease recurrence and death in upper tract urothelial carcinoma , 2013, BJU international.

[7]  M. Babjuk,et al.  Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. , 2012, The Journal of urology.

[8]  David A. Green,et al.  Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery. , 2012, European urology.

[9]  P. Massion,et al.  Smoking Induces Epithelial-to-Mesenchymal Transition in Non–Small Cell Lung Cancer through HDAC-Mediated Downregulation of E-Cadherin , 2012, Molecular Cancer Therapeutics.

[10]  H. Miyake,et al.  Expression profile of E-cadherin and N-cadherin in urothelial carcinoma of the upper urinary tract is associated with disease recurrence in patients undergoing nephroureterectomy. , 2011, Urology.

[11]  T. O'brien,et al.  Prevention of bladder tumours after nephroureterectomy for primary upper urinary tract urothelial carcinoma: a prospective, multicentre, randomised clinical trial of a single postoperative intravesical dose of mitomycin C (the ODMIT-C Trial). , 2011, European urology.

[12]  J. Witjes,et al.  Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. , 2011, European urology.

[13]  C. Kwak,et al.  Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract. , 2011, Urologic oncology.

[14]  A. Vicens,et al.  Concomitant carcinoma in situ and tumour size are prognostic factors for bladder recurrence after nephroureterectomy for upper tract transitional cell carcinoma , 2010, BJU international.

[15]  J. Nakashima,et al.  Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of recurrence in patients with nonmetastatic renal cell carcinoma. , 2010, The Journal of urology.

[16]  Y. Matsuno,et al.  Pathological characteristics and clinical course of bladder tumour developing after nephroureterectomy , 2010, BJU international.

[17]  D. Silverman,et al.  A case-control study of smoking and bladder cancer risk: emergent patterns over time. , 2009, Journal of the National Cancer Institute.

[18]  P. Tsai,et al.  Significant predictive factors for prognosis of primary upper urinary tract cancer after radical nephroureterectomy in Taiwanese patients. , 2008, European urology.

[19]  Y. Sugimura,et al.  Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma , 2008, International journal of urology : official journal of the Japanese Urological Association.

[20]  C. Shun,et al.  Stopping smoking might reduce tumour recurrence in nonmuscle‐invasive bladder cancer , 2007, BJU international.

[21]  W. Oosterlinck.  Ureteral tumour: a specific upper urinary tract transitional cell carcinoma. , 2007, European urology.

[22]  E. Messing,et al.  Promotion of bladder cancer development and progression by androgen receptor signals. , 2007, Journal of the National Cancer Institute.

[23]  P. Rehak,et al.  Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location , 2006, BJU international.

[24]  A. Schatzkin,et al.  Reproductive factors, exogenous hormone use and bladder cancer risk in a prospective study , 2006, International journal of cancer.

[25]  S. Boorjian,et al.  Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology , 2005, BJU international.

[26]  K. Yoshimura,et al.  Risk factors for subsequent development of bladder cancer after primary transitional cell carcinoma of the upper urinary tract. , 2005, Urology.

[27]  Y. Shiue,et al.  The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract , 2003, Cancer.

[28]  P. Adab,et al.  Does smoking status influence the prognosis of bladder cancer? A systematic review , 2002, BJU international.

[29]  E Dorant,et al.  The impact of characteristics of cigarette smoking on urinary tract cancer risk , 2000, Cancer.

[30]  N. Masumori,et al.  Risk factors for the development of bladder cancer after upper tract urothelial cancer. , 2000, Urology.

[31]  P. Russo,et al.  Influence of smoking status on the disease‐related outcomes of patients with tobacco‐associated superficial transitional cell carcinoma of the bladder , 1999, Cancer.

[32]  W. Sauerbrei,et al.  Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. , 1994, Journal of the National Cancer Institute.

[33]  D. Silverman,et al.  Cigarette smoking and cancers of the renal pelvis and ureter. , 1992, Cancer research.

[34]  J. Stockman,et al.  Association Between Smoking and Risk of Bladder Cancer Among Men and Women , 2013 .

[35]  C. Marsit,et al.  Carcinogen exposure and gene promoter hypermethylation in bladder cancer. , 2006, Carcinogenesis.